Serum concentration of γGT is a surrogate marker of hepatic TNF-α mRNA expression in chronic hepatitis C

Clinical Immunology

Volumn 105, Issue 3, 2002, Pages 279-285

  Taliani, Gloria ^a   Badolato, Maria Concetta ^b   Nigro, Giovanni ^c   Biasin, Mara ^d   Boddi, Vieri ^a   Pasquazzi, Caterina ^b   Clerici, Mario ^d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

HCV chronic hepatitis; HCV RNA kinetic; IFN treatment; Predictors of response; TNF ; GT levels

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOCHEMICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; ALPHA2B INTERFERON; BIOLOGICAL MARKER; MESSENGER RNA;

ADULT; AGED; ANTIBODY TITER; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MESSENGER RNA SYNTHESIS; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIREMIA; BLOOD; GENETICS; LIVER; METABOLISM; MIDDLE AGED;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LIVER; MALE; MIDDLE AGED; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036882319     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5288     Document Type: Article

References (30)

1. Davis, G. L., Ballart, R. A., Schiff, E. R., Lindsay, K., Bodenheimer, H. C., Perrillo, R. P., Carey, W., Jacobson, I. M., Payne, J., Dienstag, J. L., Van Thiel, D. H., Tamburro, C., Lefkowitch, J., Albrecht, J., Meschievitz, E. C., Ortego, T. J., Gibas, A., and the Internventional Therapy Group, Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter, randomized, controlled trial. N. Engl. J. Med. 321, 1501-1506, 1989.
2. Poynard, T., Bedossa, P., Chevallier, M., Mathurin, P., Lemonnier, C., Trepo, C., Couzigou, P., Payen, J. L., Sajus, M., Costa, J. M., Vidaud, M., Chaput, J. C., and the Multicenter Study Group, A comparison of three interferon alpha-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N. Engl. J. Med. 332, 1457-1462, 1995.
3. Ryff, J. C., Usefulness of interferon for treatment of hepatitis C. J. Hepatol. 22(Suppl. 1), 101-109, 1995.
4. Marcellin, P., Boyer, N., Gervais, A., Martinot, M., Pouteau, M., Castelnau, C., Kilani, A., Areias, J., Auperin, A., Benhamou, J. P., Degot, C., and Erlinger, S., Long-term histologic improvement and loss of detectable intrahepatic HCV-RNA in patients with chronic hepatitis C and sustained response interferon alpha therapy. Ann. Intern. Med. 127, 875-881, 1997.
5. Koff, R. S., Interferon alpha for chronic hepatitis C: Reducing the uncertainties. Ann. Intern. Med. 127, 918-920, 1997.
6. Matsumoto, A., Tanaka, E., Suzuki, T., Ogata, H., and Kiyosawa, K., Viral and host factors that contribute to efficacy of interferon-α2b therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 39, 1273-1280, 1994.
7. Davis, G. L., Lindsay, K., Albrecht, J., Bodenheimer, H. C., Balart, L. A., Perrillo, R. P., Dienstag, J. L., Tamburro, C., Schii, E. R., Carey, W., Payne, J., Jaconson, I. M., Van Thiel, D. H., Lefkowitch, J., Sanghvi, B., and the Hepatitis Interventional Therapy Group, Clinical predictors of response to recombinant interferon-α treatment in chronic non-A, non-B hepatitis (hepatitis C). J. Viral Hepatitis 1, 55-63, 1994.
8. Chemello, L., Cavalletto, L., Noventa, F., Bonetti, P., Casarin, C., Bernardinello, E., Pontisso, P., Donada, C., Casarin, P., Belussi, F., Frezza, M., and Alberti, A., Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-α. J. Viral Hepatitis 2, 91-96, 1995.
9. Yoshioka, K., Higashi, Y., Yamada, M., Aiyama, T., Takayanagi, M., Tanaka, K., Okumura, A., Iwata, K., and Kakumu, S., Predictive factors in the response to interferon therapy in chronic hepatitis C. Liver 15, 57-62, 1995.
10. Mazzella, G., Salzetta, A., Casanova, S., Morelli, M. C., Villanova, N., Miniero, R., Sottili, S., Novelli, V., Cipolla, A., Festi, D., and Roda, E., Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: Gamma GT levels predictive of response. Dig. Dis. Sci. 39, 866-870, 1994.
11. Sheron, N., Lau, J. Y. N., Danielsm, H. M., Webster, J., Eddleston, A. L. W., Alexander, G. J. M., and Williams, R., Tumor necrosis factor to treat chronic hepatitis B virus infection. Lancet 336, 321-322, 1990.
12. Larrea, E., Garcia, N., Qian, C., Civeira, M. P., and Prietom, J., Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C. Hepatology 23, 210-217, 1996.
13. Nelson, D. R., Lim, H. L., Marousis, C. G., Fang, J. W. S., Davis, G. L., Shen, L., Urdea, M. S., Kolberg, J. A., and Lau, Y. N., Activation of tumor necrosis factor-α system in chronic hepatitis C virus infection. Dig. Dis. Sci. 42, 2487-2494, 1997.
14. Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., Phillips, M. J., Portman, B. G., Poulsen, H., Scheuer, P. J., Schmid, M., and Thaler, H., Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696-699, 1995.
15. Taliani, G., Badolato, M. C., Lecce, R., Poliandri, G., Bozza, A., Duca, F., Pasquazzi, C., Clementi, C., Furlan, C., and De Bac, C., Hepatitis C virus RNA in peripheral blood mononuclear cells: Relation with the response to interferon treatment. J. Med. Virol. 47, 16-22, 1995.
16. Taliani, G., Celestino, D., Badolato, M. C., Pennica, A., Bozza, A., Poliandri, G., Riccieri, V., Benfari, G., Sebastiani, A., De Bac, C., Quarantam, G., and Aceti, A., Hepatitis C virus and salivary gland infection: Lack of correlation. J. Hepatol. 26, 1200-1206, 1997.
17. Tomei, L., Failla, C., Santolini, E., Santolini, E., De Francesco, R., and La Monica, N., NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 67, 4017-4026, 1993.
18. Saldanha, J., Lelie, N., and Heath, A., Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study Group. Vox. Sang. 76, 149-158, 1999.
19. Simmonds, P., Mc Omish, F., Yap, P. L., Chan, S. W., Lin, C. K., Dusheiko, G., Saeed, A. A., and Holmesb, E. C., Sequence variability in the 5′ non-coding region of hepatitis C virus: Identification of a new virus type and restriction sequence diversity. J. Gen. Virol. 74, 661-668, 1993.
20. Stuyver, L., Rossau, R., Wyseur, A., Duhamel, M., Vanderborght, B., Heuverswyn, H. V., and Maertens, G., Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J. Gen. Virol. 74, 1093-1102, 1993.
21. Clerici, M., Seminari, E., and Suter, F., Different immunological profiles characterize HIV infection in HAART-treated and antiretroviral-naive patients with undetectable viremia. AIDS 14, 109-116, 2000.
22. Chomczinsky, P., and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-choloform extraction. Anal. Biochem. 162, 156-159, 1987.
23. Kowdley, K. W., TNF-α in chronic hepatitis C: The smoking gun? Am. J. Gastroenterol. 194, 1132-1135, 1999.
24. Gonzales-Amaro, R., Garcia-Monzon, C., Garcia-Buey, L., Moreno-Otero, R., Alonso, J. L., Yague, E., Pivel, J. P., Lopez-Cabrera, M., Fernandez-Ruiz, E., and Sanchez-Madrid, F., Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179, 841-848, 1994.
25. Fukuda, R., Ishimura, N., Ishihara, S., Chowdhuri, A., Moriyama, N., Nogami, C., Miyake, T., Niigaki, M., Tokuda, A., Satoh, S., Sakai, S., Akagi, S., Watanabe, M., and Fukumoto, S., Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver 16, 390-399, 1996.
26. Kallinowski, B., Haseroth, K., Marinos, G., Hanck, C., Stremmel, W., Theilemann, L., Singer, M. V., and Rossol, S., Induction of tumor necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin. Exp. Immunol. 111, 269-277, 1998.
27. Kakumu, S., Okumura, A., Ishikawa, T., Enomoto, A., Nishimura, H., Yoshioka, K., and Yoshika, Y., Serum levels of IL-10, IL-15 and soluble tumor necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin. Exp. Immunol. 109, 458-463, 1997.
28. Itoh, Y., Okanoue, T., Ohnishi, N., Sakamoto, M., Nishioji, K., Nakagawa, Y., Minami, M., Murakami, Y., and Kashima, K., Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 94, 1332-1340, 1999.
29. Dumoulin, F. L., Wennrich, U., Nischalke, H. D., Leifeld, L., Fischer, H. P., Sauerbruch, T., and Spengler, U., Intrahepatic mRNA levels of interferon γ and tumor necrosis factor α and response to antiviral treatment of chronic hepatitis C. J. Hum. Virol. 4, 195-199, 2001.
30. Guidotti, L. G., and Chisari, F. V., Cytokine-induced viral purging - Role in viral pathogenesis. Curr. Opin. Microbiol. 2, 388-391, 1999.